OMGCX
Price
$22.46
Change
-$0.11 (-0.49%)
Updated
Jul 31 closing price
Net Assets
12.12B
PAMCX
Price
$93.07
Change
-$0.30 (-0.32%)
Updated
Jul 31 closing price
Net Assets
22.11B
Interact to see
Advertisement

OMGCX vs PAMCX

OMGCX vs PAMCX Comparison Chart in %
View a ticker or compare two or three
VS
OMGCX vs. PAMCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OMGCX is a Buy and PAMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 22.1B vs. OMGCX (12.1B). OMGCX (0.00) and PAMCX (0.00) have matching dividends . OMGCX was incepted earlier than PAMCX: OMGCX (29 years) vs PAMCX (26 years). OMGCX (1.72) is less costly to investors than PAMCX (1.02). OMGCX is a more actively managed with annual turnover of: 67.00 vs. PAMCX (31.50). OMGCX has a lower initial minimum investment than PAMCX: OMGCX (1000) vs PAMCX (2500). PAMCX annual gain was more profitable for investors over the last year : -2.54 vs. OMGCX (-16.81). PAMCX return over 5 years is better than : -23.44 vs. OMGCX (-31.61).
OMGCXPAMCXOMGCX / PAMCX
Total Expense Ratio1.591.02156%
Annual Report Gross Expense Ratio1.721.02169%
Fund Existence29 years26 years-
Gain YTD1.5372.25268%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets12.1B22.1B55%
Annual Yield % from dividends0.000.00-
Returns for 1 year-16.81-2.54661%
Returns for 3 years-5.79-5.35108%
Returns for 5 years-31.61-23.44135%
Returns for 10 years14.0724.0459%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SLCGX30.830.26
+0.85%
Saratoga Large Capitalization Growth I
BERIX14.38-0.01
-0.07%
Carillon Chartwell Real Income I
PCCGX12.40-0.03
-0.24%
Victory Pioneer Mid Cap Value C
EISMX38.54-0.25
-0.64%
Eaton Vance Atlanta Capital SMID-Cap I
FBTTX40.89-0.99
-2.36%
Fidelity Advisor Biotechnology M